Guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections in Taiwan.

The Infectious Diseases Society of Taiwan; Medical Foundation in Memory of Dr. Deh-Lin Cheng; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education; CY Lee’s Research Foundation for Pediatric Infectious Diseases and Vaccines Consensus Conference Participants (in alphabetical order): Ren-Jy Ben, Yu-Jiun Chan, Feng-Yee Chang, Shan-Chwen Chang, Chih-Jung Chen, Po-Yen Chen, Te-Li Chen, Yao-Shen Chen, Yee-Chun Chen, Yu-Jung Chen, Ming-Fang Cheng, Cheng-Hsun Chiu, Ming-Yuan Chou, Yin-Ching Chuang, Chang-Phone Fung, Szu-Min Hsieh, Wei-Chuan Hsieh, Po-Ren Hsueh, Cheng-Hua Huang, Fu-Yuan Huang, Li-Min Huang, Yhu-Chering Huang, Yung-Feng Huang, Chien-Ching Hung, Yeu-Jun Lau, Chin-Yun Lee, Ping-Ing Lee, Sai-Cheong Lee, Susan Shin-Jung Lee, Hsieh-Shong Leu, Hsi-Hsun Lin, TzouYien Lin, Yi-Sheng Liou, Cheng-Yi Liu, Ching-Chuan Liu, JienWei Liu, Yung-Ching Liu, Po-liang Lu, Kwen-Tay Luh, WangHuei Sheng, Zhi-Yuan Shi, Chen-Yi Su, Cheng Len Sy, Che-An Tsai, Fu-Der Wang, Jiun-Ling Wang, Shue-Ren Wann, WingWai Wong, Muh-Yong Yen, Kwok-Woon Yu. Methicillin-resistant Staphylococcus aureus (MRSA) continues to be one of most important causes of health careassociated infections. Its ubiquity and increasing vancomycin nonsusceptibility have contributed to the complexity of treatment of infections caused by this pathogen. Guidelines on the therapeutic monitoring of vancomycin and treatment of MRSA infections were recently issued by the Infectious Disease Society of America. In the advent of the issuance of these guidelines, a symposium on the “Treatment of MRSA Infections in Taiwan” was held in early